Cargando…

Quantitative Proteomic Analysis and Evaluation of the Potential Prognostic Biomarkers in Cholangiocarcinoma

Background & Aims: Cholangiocarcinoma (CCA) patients have poor outcomes since the late diagnosis limits the benefits of surgery therapy and curative treatment options. The present study was designed to screen the biomarkers for CCA patients. Methods: Quantitative iTRAQ proteomic analysis was use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Zengwei, Yang, Yuan, Zhang, Jinduo, Fu, Wenkang, Lin, Yanyan, Su, Gang, Li, Yan, Meng, Wenbo, Li, Xun, Xie, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692627/ https://www.ncbi.nlm.nih.gov/pubmed/31417643 http://dx.doi.org/10.7150/jca.29354

Ejemplares similares

Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma
por: Da, Zijian, et al.
Publicado: (2020)

Curcumol Exerts Anticancer Effect in Cholangiocarcinoma Cells via Down-Regulating CDKL3
por: Zhang, Jinduo, et al.
Publicado: (2018)

Effect of preoperative cholangitis on prognosis of patients with hilar cholangiocarcinoma: A systematic review and meta-analysis
por: Wang, Yudong, et al.
Publicado: (2018)

The role of extracellular vesicles in cholangiocarcinoma
por: Bai, Mingzhen, et al.
Publicado: (2020)

Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma
por: Tang, Zengwei, et al.
Publicado: (2019)

The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis
por: Tang, Zengwei, et al.
Publicado: (2018)

Identification and Comparison of Differentiation-Related Proteins in Hepatocellular Carcinoma Tissues by Proteomics
por: Zhao, Sheng, et al.
Publicado: (2017)

Preoperative prognostic nutritional index predicts short-term complications after radical resection of distal cholangiocarcinoma
por: He, Yulong, et al.
Publicado: (2023)

Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis
por: Mi, Ningning, et al.
Publicado: (2020)

Best option for preoperative biliary drainage in Klatskin tumor: A systematic review and meta-analysis
por: Tang, Zengwei, et al.
Publicado: (2017)

Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ-based quantitative proteomics analysis
por: Ren, Hongyue, et al.
Publicado: (2019)

Early precut sphincterotomy does not increase the risk of adverse events for patients with difficult biliary access: A systematic review of randomized clinical trials with meta-analysis and trial sequential analysis
por: Tang, Zengwei, et al.
Publicado: (2018)

Phosphoproteomics reveals that cinobufotalin promotes intrahepatic cholangiocarcinoma cell apoptosis by activating the ATM/CHK2/p53 signaling pathway
por: Xia, Zhili, et al.
Publicado: (2022)

Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma
por: Li, Hanyu, et al.
Publicado: (2019)

Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma
por: Gao, Long, et al.
Publicado: (2023)

Quantitative proteomic analysis of bile in extrahepatic cholangiocarcinoma patients
por: Son, Kuk Hui, et al.
Publicado: (2020)

Correction: Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma
por: Gao, Long, et al.
Publicado: (2023)

Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma
por: Shen, Jian, et al.
Publicado: (2012)

A Prospective Proteomic-Based Study for Identifying Potential Biomarkers for the Diagnosis of Cholangiocarcinoma
por: Shi, Yuan, et al.
Publicado: (2013)

Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2023)

Correction: Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2023)

Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling
por: Tang, Zengwei, et al.
Publicado: (2023)

LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
por: Ong, Khaa Hoo, et al.
Publicado: (2023)

Quantitative proteomics characterization of cancer biomarkers and treatment
por: Yang, Xiao-Li, et al.
Publicado: (2021)

Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma
por: Wang, Li-Juan, et al.
Publicado: (2015)

ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma
por: Liu, Pei, et al.
Publicado: (2022)

Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma
por: Xu, Lin, et al.
Publicado: (2021)

Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma
por: Zhai, Xiangyu, et al.
Publicado: (2020)

Podoplanin is an important stromal prognostic marker in perihilar cholangiocarcinoma
por: Obulkasim, Halmurat, et al.
Publicado: (2018)

Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients
por: Bai, Bing, et al.
Publicado: (2019)

Comparison of endoscopic naso-gallbladder drainage and percutaneous transhepatic gallbladder drainage in acute suppurative cholecystitis: Study Protocol Clinical Trial (SPIRIT Compliant)
por: Mu, Peilei, et al.
Publicado: (2020)

KIF4A as a novel prognostic biomarker in cholangiocarcinoma
por: Zhang, Deng Yong, et al.
Publicado: (2021)

Identification of therapeutic targets and prognostic biomarkers in cholangiocarcinoma via WGCNA
por: Xu, Lei, et al.
Publicado: (2022)

Identification of Cofilin‐1 as a novel biomarker of atopic dermatitis using iTRAQ quantitative proteomics
por: Zhou, Xiaotao, et al.
Publicado: (2022)

Discovery of Prognostic Biomarker Candidates of Lacunar Infarction by Quantitative Proteomics of Microvesicles Enriched Plasma
por: Datta, Arnab, et al.
Publicado: (2014)

Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology
por: Villar, Margarita, et al.
Publicado: (2021)

Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma
por: Jiang, Tao, et al.
Publicado: (2021)

Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers
por: Zhao, Li, et al.
Publicado: (2019)

Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
por: Su, Miao, et al.
Publicado: (2021)

Quantitative proteomics for identifying biomarkers for Rabies
por: Venugopal, Abhilash K, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6ot0k7lfsdgv10blq951ubl1e6